Correlation Between Reviva Pharmaceuticals and Synaptogenix

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Synaptogenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Synaptogenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Synaptogenix, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Synaptogenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Synaptogenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Synaptogenix.

Diversification Opportunities for Reviva Pharmaceuticals and Synaptogenix

0.71

Correlation Coefficient

Reviva Pharmaceuticals  Synaptogenix

Poor diversification

The 3 months correlation between Reviva and Synaptogenix is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Synaptogenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synaptogenix and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Synaptogenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synaptogenix has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Synaptogenix go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Synaptogenix

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to under-perform the Synaptogenix. In addition to that, Reviva Pharmaceuticals is 1.29 times more volatile than Synaptogenix. It trades about -0.14 of its total potential returns per unit of risk. Synaptogenix is currently generating about -0.07 per unit of volatility. If you would invest  337.00  in Synaptogenix on December 30, 2024 and sell it today you would lose (69.00) from holding Synaptogenix or give up 20.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Synaptogenix

Reviva Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Reviva Pharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Synaptogenix

Risk-Adjusted Performance

Very Weak

Over the last 90 days Synaptogenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Reviva Pharmaceuticals and Synaptogenix

The main advantage of trading using opposite Reviva Pharmaceuticals and Synaptogenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Synaptogenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synaptogenix will offset losses from the drop in Synaptogenix's long position.

The idea behind Reviva Pharmaceuticals Holdings and Synaptogenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.